Skip to main content
. 2021 Sep 30;4(4):196–207. doi: 10.36401/JIPO-21-14

Figure 4.

Figure 4

Forrest plot for meta-analysis of prevalence of medication-related osteonecrosis of the jaw in patients administered concurrent bevacizumab and antiresorptive drugs. Red square: weighted prevalence estimate of individual study; horizontal black line: 95% CI of individual study result; diamond: pooled prevalence estimate.